Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PANDIA IRIS: Patients With Diabetes and Kidney Failure, an Interdisciplinary Medication Adherence Support Program

NCT04190251 is registered in ClinicalTrials.gov with Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland as lead sponsor.

NCT NCT04190251
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04190251 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PANDIA IRIS: Patients With Diabetes and Kidney Failure, an Interdisciplinary Medication Adherence Support Program
Lead sponsor
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
Phase
Not applicable
Overall status
Completed
Start date
April 14, 2016
Completion date
December 20, 2022
Enrollment
73 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, renal insufficiency, chronic